Literature DB >> 30689791

Results of surgical management of infective endocarditis associated with Staphylococcus aureus.

Kota Suzuki1, Daisuke Yoshioka1, Koichi Toda1, Jun-Ya Yokoyama1, Takaaki Samura1, Shigeru Miyagawa1, Yasushi Yoshikawa1, Hiroki Hata1, Hiroshi Takano2, Goro Matsumiya3, Taichi Sakaguchi4, Hirotsugu Fukuda5, Yoshiki Sawa1.   

Abstract

OBJECTIVES: Staphylococcus aureus (SA) is a leading cause of infective endocarditis (IE), and such cases are on the rise. Our objective was to evaluate the clinical outcomes of surgical intervention in patients with SA-associated IE and to identify the factors associated with outcomes.
METHODS: Between 2009 and 2017, 585 patients underwent valve surgery for definitive left-sided IE at 14 affiliated hospitals. Their medical records were retrospectively reviewed, and the preoperative variables and clinical results of patients with (n = 117) or without SA infection (n = 468) were compared.
RESULTS: The SA group had a more critical preoperative condition with higher rates of chronic haemodialysis, preoperative embolic events and preoperative inflammation levels, as well as worse renal function. In-hospital mortality was 20% and 7% in the patients with or without SA infection, respectively. The overall survival rate at 1 year and 5 years was 72% and 62% in the SA group, and 88% and 81% in the non-SA group, respectively (P < 0.001). The Cox hazard analysis revealed that methicillin-resistant SA infection was an independent risk factor for overall mortality in the SA group. The rate of freedom from recurrence of endocarditis at 1 year and 5 years was 95% and 90% in the SA group and 96% and 92% in the non-SA group, respectively (P = 0.43).
CONCLUSIONS: The short- and mid-term outcomes after valve surgery for active IE in patients with SA are still challenging. Methicillin-resistant SA infection is an independent predictor of mid-term mortality.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  zzm321990 Staphylococcus aureuszzm321990 ; Infective endocarditis; Valve surgery

Mesh:

Year:  2019        PMID: 30689791     DOI: 10.1093/ejcts/ezy470

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

1.  Outcome of surgery for acute infective endocarditis: does preoperative stroke have an impact on mortality?

Authors:  Nadejda Monsefi; Mahmut Öztürk; Tunjay Shavahatli; Ali Ahmad El-Sayed; Farhad Bakhtiary
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-03-23

2.  Diabetes Mellitus: An Independent Risk Factor of In-Hospital Mortality in Patients with Infective Endocarditis in a New Era of Clinical Practice.

Authors:  Cheng-Jei Lin; Sarah Chua; Sheng-Ying Chung; Chi-Ling Hang; Tzu-Hsien Tsai
Journal:  Int J Environ Res Public Health       Date:  2019-06-25       Impact factor: 3.390

Review 3.  Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies.

Authors:  Joop J P Kouijzer; Daniëlle J Noordermeer; Wouter J van Leeuwen; Nelianne J Verkaik; Kirby R Lattwein
Journal:  Front Cell Dev Biol       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.